check_circleStudy Completed

Diagnostic Imaging

Iopromide (SHL414A) versus amidotrizoate (Visotrast-370) in angiocardiography in 50 newborns and infants

Trial purpose

Please see attached Study Results Summary below

Key Participants Requirements

Sex

N/A

Age

13 - 3 Years
  • -

  • -

Trial summary

Enrollment Goal
50
Trial Dates
July 1986 - April 1987
Phase
Phase 4
Could I Receive a placebo
N/A
Products
Ultravist (Iopromide, BAY86-4877)
Accepts Healthy Volunteer
N/A

Trial design

Double-blind comparative clinical study of iopromide (SHL414A) versus amidotrizoate (Visotrast-370) in angiocardiography in 50 newborns and infants
Trial Type
Interventional
Intervention Type
N/A
Trial Purpose
N/A
Allocation
N/A
Blinding
N/A
Assignment
N/A
Trial Arms
N/A